Credelio Chewable Tablets for Cats: SPC Update
Change to the information provided on adverse events in the Summary of Product Characteristics for Credelio 12mg and 48mg chewable tablets for cats.
Following monitoring of pharmacovigilance data, the Summary of Product Characteristics (SPC) for Credelio Chewable tablets 12mg and 48mg for cats has been updated.
Anorexia, lethargy, tachypnoea, ataxia, muscle tremor, hyperactivity and pruritus can occur very rarely as an adverse event.
Any veterinary medicinal product which is authorised for marketing in the United Kingdom will have its Summary of Product Characteristics (SPC) available on our Product Information Database .
No medicine is 100% risk free, the SPC includes information on what adverse events have been known to occur following administration of a particular product, these can be found in either section Adverse events (3.6) or Adverse reactions (4.6).
All updates to SPCs other than template changes, are published in the medicine updates section of VMD Connect .
https://www.gov.uk/government/news/credelio-12mg-and-48mg-chewable-tablets-for-cats-spc-change